EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

Global prevalence of cervical human papillomavirus in women aged 50 years and older with normal cytology: a systematic review and meta-analysis

Vanesa Osmani, Lucy Hörner, Theoneste Nkurunziza, Sophia Rank, Luana Fiengo Tanaka, Stefanie J Klug

The Lancet Microbe · 2025-01 · 6 (1) · 100955

DOI: 10.1016/j.lanmic.2024.100955 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Lancet Microbe, 2025-01. Verfasst von Vanesa Osmani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chair of Epidemiology, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany. Electronic address: vanesa.osmani@tum.de. Hauptthemen laut MEDLINE: Papillomavirus Infections, Papillomaviridae, Cervix Uteri. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Given the paucity of up-to-date empirical data on human papillomavirus (HPV) among older women, we aimed to estimate the global HPV prevalence in women aged 50 years and older with normal cytology. METHODS: In this systematic review and meta-analysis, we searched for quantitative studies (cross-sectional, longitudinal, case-control, randomised control trials) reporting HPV prevalence among women aged 50 years and older with normal cytology published until May 31, 2022, in PubMed, Scopus, and Web of Science. The risk of bias was assessed using a modified Newcastle-Ottawa scale. The pooled prevalence and 95% CIs of any-HPV and high-risk (HR)-HPV were estimated using random-effects models. Geographical differences were assessed in stratified meta-analyses and multiple meta-regression models. The prevalence by 5-year age groups and genotypes was estimated when reported using mixed-effects models. The study protocol was registered with PROSPERO (CRD42021241365). FINDINGS: From 9099 identified articles, 132 were included in the qualitative synthesis. 91 (68·9%) studies were deemed to have a low risk of bias and 41 (31·1%) a high risk of bias. We estimated a worldwide pooled any-HPV prevalence of 11·70% (95% CI 9·68-13·87) from 73 studies including 41 745 women and an HR-HPV prevalence of 6·45% (5·45-7·53) from 102 studies including 437 228 women. The pooled prevalence varied geographically, with the highest estimates in western Africa (any-HPV: 32·26% [4·53-70·22]; HR-HPV: 16·20% [0·70-45·95]) and central America (any-HPV: 24·50% [9·97-42·93]; HR-HPV: 13·52% [9·48-18·14]), and the lowest in western Europe (any-HPV: 5·98% [3·08-9·77]; HR-HPV: 4·09% [2·37-6·25]) and western Asia (for HR-HPV only: 3·27% [0·00-20·91]). Worldwide, any-HPV prevalence generally decreased with age, from 10·74% (5·84-18·95) at 50-54 years to 3·56% (2·33-5·40) after age 75 years. HR-HPV prevalence decreased from 6·04% (4·33-8·38) at age 50-54 years to 4·61% (3·25-6·51) at 60-64 years, increased again to 6·33% (4·03-9·79) at 65-69 years, and then decreased to 5·28% (2·83-9·63) after age 75 years. HPV types 16 (1·17% [0·67-2·03]) and 53 (0·90% [0·43-1·90]) were the most prevalent globally. INTERPRETATION: HPV prevalence in women aged 50 years and older with normal cytology varies globally and mostly correlates with the cervical cancer burden. Research on HPV persistence, progression, and cost-effectiveness of HPV testing among older women should be conducted to fully inform future cervical cancer screening policies. FUNDING: None.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsPapillomaviridaeCervix UteriHumansFemalePrevalenceMiddle AgedGlobal HealthAgedGenotypeUterine Cervical NeoplasmsCross-Sectional StudiesHuman Papillomavirus Viruses

Autor:innen und Institutionen

  • Chair of Epidemiology, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany. Electronic address: vanesa.osmani@tum.de.
  • Chair of Epidemiology, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.

Zitieren

APA

Osmani, V., Hörner, L., Nkurunziza, T., Rank, S., Tanaka, L. F., & Klug, S. J. (2025). Global prevalence of cervical human papillomavirus in women aged 50 years and older with normal cytology: a systematic review and meta-analysis. The Lancet Microbe, 6(1), 100955. https://doi.org/10.1016/j.lanmic.2024.100955

Vancouver

Osmani V, Hörner L, Nkurunziza T, Rank S, Tanaka LF, Klug SJ. Global prevalence of cervical human papillomavirus in women aged 50 years and older with normal cytology: a systematic review and meta-analysis. The Lancet Microbe. 2025;6(1):100955. doi:10.1016/j.lanmic.2024.100955

BibTeX
@article{Osmani2025,
  author = {Osmani, Vanesa and Hörner, Lucy and Nkurunziza, Theoneste and Rank, Sophia and Tanaka, Luana Fiengo and Klug, Stefanie J},
  title = {Global prevalence of cervical human papillomavirus in women aged 50 years and older with normal cytology: a systematic review and meta-analysis},
  journal = {The Lancet Microbe},
  year = {2025},
  volume = {6},
  number = {1},
  pages = {100955},
  doi = {10.1016/j.lanmic.2024.100955}
}
Kostenlos starten →